相关实验视频
Updated: Jun 21, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
在日本的老年人中,他类药物使用与痴呆风险的关联:使用LIFE研究进行的嵌套病例对照研究
Sanyu Ge1, Tetsuhisa Kitamura1, Ling Zha1
1Department of Social Medicine, Division of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
Journal of Alzheimer's disease : JAD
|July 5, 2024
概括
在日本老年人中,使用他类药物与较低的痴呆风险有关. 较高的累积他类药物剂量显示出保护作用,而低剂量与痴呆症风险增加有关.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 以前的研究表明,他类药物的使用与痴呆症风险降低之间存在潜在联系.
- 这种关联需要进一步证实,特别是在日本人口快速老龄化方面.
研究的目的:
- 调查65岁及以上日本人使用他类药物与痴呆风险之间的关联.
- 分析累积他类药物剂量对该人口群体痴呆风险的影响.
主要方法:
- 使用长寿改善和公平证据 (LIFE) 研究的数据,采用了一个嵌套的病例控制研究设计.
- 分析了来自17个市镇的医疗和长期护理索赔数据 (2014年4月至2020年12月).
- 条件后勤回归被用来计算几率比率 (ORs) 和95%置信区间 (CI),将病例与五个对照进行匹配.
主要成果:
- 该研究包括57,302例病例和283,525例对照,其中59.7%是女性参与者.
- 立方体使用与痴呆症 (OR:0.70) 和阿尔茨海默病 (OR:0.66) 的风险明显降低.
- 剂量反应分析显示,低累积他类药物剂量 (1-30个TSDD) 增加了痴呆症风险,高剂量 (>91个TSDD) 增加了保护作用.
结论:
- 静止剂的使用与日本老年人痴呆和阿尔茨海默病的风险降低有关.
- 存在一种剂量依赖的关系,较高的累积他类药物剂量提供了更大的预防痴呆的保护.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
628
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
628
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
Alzheimer's Disease: Treatment
177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
152
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
152

